Alessandra Latini
Overview
Explore the profile of Alessandra Latini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tedesco M, Bellei B, Alei L, Di Prete M, Cota C, Pallara T, et al.
Dermatol Reports
. 2025 Feb;
PMID: 39969047
Lichen sclerosus (LS) is a chronic scleroatrophic dermatosis of unknown etiology that usually affects the anogenital area and occasionally the extragenital sites, which has no definitive cure. LS patients are...
2.
Capodieci S, Zaccarelli M, Stingone C, Giuliani E, Cafaro V, Gianserra L, et al.
BMC Public Health
. 2025 Feb;
25(1):600.
PMID: 39948546
Background: Chemsex, characterized by the intentional use of specific drugs to enhance sexual experiences during group sessions, represents a challenge for the health of some sexually active communities, such as...
3.
Benevolo M, Giuliani M, Rossi P, Rollo F, Giuliani E, Stingone C, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39936264
The International Anal Neoplasia Society (IANS) has generated recommendations for anal cancer screening, identifying MSM living with HIV (MSM-LWH) ≥35 years and MSM-noHIV ≥45 years as groups to prioritize. Since...
4.
Mazzotta V, Piselli P, Lepri A, Matusali G, Cimini E, Esvan R, et al.
Vaccines (Basel)
. 2025 Jan;
13(1).
PMID: 39852811
Background: The recent resurgence of mpox in central Africa has been declared a new public health emergency of international concern (PHEIC) requiring coordinated international responses. Vaccination is a priority to...
5.
Escobar Marcillo D, Privitera G, Rollo F, Latini A, Giuliani E, Benevolo M, et al.
Sci Rep
. 2025 Jan;
15(1):2953.
PMID: 39848958
Microbiome gained attention as a cofactor in cancers originating from epithelial tissues. High-risk (hr)HPV infection causes oropharyngeal squamous cell carcinoma but only in a fraction of hrHPV+ individuals, suggesting that...
6.
Capodieci S, Zaccarelli M, Stingone C, Giuliani E, Giuliani M, Cafaro V, et al.
Sex Transm Infect
. 2024 Sep;
100(8):542.
PMID: 39266218
No abstract available.
7.
Di Prete M, Latini A, Lora V, Pimpinelli F, Cota C
J Cutan Pathol
. 2024 Aug;
51(11):866-867.
PMID: 39140192
No abstract available.
8.
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, et al.
J Antimicrob Chemother
. 2024 Jul;
79(9):2152-2162.
PMID: 39028674
Background: Transmitted drug resistance (TDR) is still a critical aspect for the management of individuals living with HIV-1. Thus, its evaluation is crucial to optimize HIV care. Methods: Overall, 2386...
9.
Vergori A, Cozzi-Lepri A, Tavelli A, Mazzotta V, Azzini A, Gagliardini R, et al.
Int J Infect Dis
. 2024 Apr;
144:107065.
PMID: 38643867
Objectives: To investigate whether SARS-CoV-2 messenger RNA (mRNA) vaccination has an impact on HIV-related viro-immunological parameters. Methods: People with HIV (PWH) in the VAXICONA-ORCHESTRA cohort who received one or more...
10.
Dona M, Giuliani E, Giglio A, Pimpinelli F, Stingone C, Giuliani M, et al.
Eur J Dermatol
. 2024 Mar;
33(6):709-710.
PMID: 38465564
No abstract available.